1 The metabolism of (+)‐, (‐)‐ and (±)‐salbutamol by sulphoconjugation was determined in vitro using human lung cytosol and bronchial epithelial BEAS‐2B cell homogenate.
2 For the lungs the intrinsic clearance (Vmax/Km) value for the pharmacologically active (‐)‐salbutamol (0.49 ± 0.32 ml min‐‐1 g‐1 protein) exceeded that of (+)‐salbutamol (0.046 ± 0.028 ml min‐1 g‐1 protein) by 11‐fold. This was mainly due to a difference in Km value, which was 16 times higher for (+)‐salbutamol (1300 ± 170 μM) than for (‐)‐salbutamol (83 ± 12 μM).
3 The stereoselectivity of sulphoconjugation of salbutamol was very similar in the BEAS‐2B cells, although the absolute activity was considerably lower.
4 The enzyme catalyzing this reaction both in the lungs and in the BEAS‐2B cells was the monoamine (M) form phenolsulphotransferase.
5 These observations emphasize that the smooth muscle of the bronchi most likely are exposed to considerably higher concentrations of the potentially toxic (+)‐enantiomer than of the bronchodilating (‐)‐enantiomer during therapy with (±)‐salbutamol.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.